Advances in the Treatment of Nasopharyngeal Cancer

  • 183

    Total Views and Downloads

About this Research Topic

Submission deadlines

  1. Manuscript Summary Submission Deadline 8 January 2025 | Manuscript Submission Deadline 28 April 2025

  2. This Research Topic is still accepting articles.

Background

Nasopharyngeal carcinoma (NPC) has several features that differ according to geographic area. For example, age distribution differs in low-incidence areas compared with endemic areas. In low-incidence areas, the incidence of NPC increases with age and has a bimodal peak: the first in adolescents and young adults and the second after 65 years of age, whereas in endemic areas, the incidence increases after 30 years of age. EBV is considered in ‘Group 1’ by the International Agency for Research on Cancer (IARC) in respect to NPC. In regions where NPC is endemic, p16 positivity and human papillomavirus (HPV) expression (screened using RNA probes to detect 13 high-risk and 5 low-risk HPV types) is reported in up to 8% of non-keratinizing undifferentiated carcinoma. The treatment of localized NPC is based on radiotherapy and chemotherapy. For advanced and metastatic disease, the addition of immunotherapy to cisplatin and gemcitabine and maintenance seems to be beneficial as first-line treatment.



EBV infection is strongly associated with NPC. Plasma EBV DNA can be used to facilitate early diagnosis and recurrence monitoring and also has prognostic value, both before and just after the end of treatment. However, more research is needed to refine the role of plasma EBV DNA in the management of NPC and to identify additional molecular markers that could lead to advances in personalized medicine in NPC. Efficacy data and consequent recommendations described here are derived largely from studies in the endemic setting, where non-keratinizing, EBV-related carcinomas constitute most cases. Where the evidence is lower, these data will still be considered for non-endemic carcinomas. The optimal treatment strategy for patients with advanced NPC should be discussed within a multidisciplinary team (MDT). Treatment of patients in high-volume facilities is recommended as this was reported as an independent prognostic factor for improved survival, at least in areas where the disease is endemic.



Recently, two randomized phase III trials showed an increase in progression-free survival (PFS) when immunotherapy (camrelizumab or toripalimab) was added to first-line treatment with cisplatin and gemcitabine followed by maintenance immunotherapy (camrelizumab or toripalimab) for recurrent and/or metastatic disease. The addition of immunotherapy should therefore be considered, pending long-term results of overall survival benefit and the assessment of the role of maintenance therapy.



This Research Topic is accepting manuscripts on, but not limited to, the following themes:



-the implication of EBV and HPV expressions in the diagnosis, treatment, and prognosis

-the place of neoadjuvant and adjuvant chemotherapy

-the evaluation of radiotherapy dose and regimen

-the role of immunotherapy in the locally advanced, nonmetastatic nasopharyngeal cancer

-the place of immunotherapy in recurrent/metastatic nasopharyngeal cancer



Types of manuscripts accepted in this Research Topic: original research, meta-analyses, reviews.



Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Editorial
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion
  • Original Research

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Nasopharyngeal cancer, EBV, HPV, diagnosis immunotherapy, radiotherapy, chemotherapy, prognosis

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 183Topic views
View impact